acetanilide has been researched along with 4-phenylcoumarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, S; Fuse, H; Itokawa, S; Kakoi, Y; Kubo, K; Marui, S; Nakada, Y; Nishimura, S; Ogino, M; Sanada, T; Tokunoh, R; Wada, T | 1 |
| Itokawa, S; Kita, S; Kubo, K; Marui, S; Nakada, Y; Negoro, N; Nishimura, S; Ogino, M; Sanada, T; Satomi, T | 1 |
2 other study(ies) available for acetanilide and 4-phenylcoumarin
| Article | Year |
|---|---|
Discovery of a potent and orally available acyl-CoA: cholesterol acyltransferase inhibitor as an anti-atherosclerotic agent: (4-phenylcoumarin)acetanilide derivatives.
Topics: Acetamides; Acetanilides; Acyl Coenzyme A; Administration, Oral; Animals; Anticholesteremic Agents; Apolipoproteins; Atherosclerosis; Benzopyrans; Cholesterol; Coumarins; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Structure-Activity Relationship | 2011 |
Discovery of a novel acyl-CoA: cholesterol acyltransferase inhibitor: the synthesis, biological evaluation, and reduced adrenal toxicity of (4-phenylcoumarin)acetanilide derivatives with a carboxylic acid moiety.
Topics: Acetanilides; Acyl Coenzyme A; Administration, Oral; Adrenal Cortex; Animals; Anticholesteremic Agents; Carboxylic Acids; Cell Line; Coumarins; Enzyme Inhibitors; Guinea Pigs; Humans; Models, Animal; Rabbits; Sterol O-Acyltransferase | 2011 |